527 related articles for article (PubMed ID: 21907261)
1. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
2. Introduction to Purinergic Signalling in the Brain.
Burnstock G
Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
[TBL] [Abstract][Full Text] [Related]
3. Introduction to purinergic signalling in the brain.
Burnstock G
Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
5. Purinergic Signalling and Neurological Diseases: An Update.
Burnstock G
CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
[TBL] [Abstract][Full Text] [Related]
6. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
7. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
8. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Franke H; Illes P
Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
10. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
Amadio S; Apolloni S; D'Ambrosi N; Volonté C
J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
[TBL] [Abstract][Full Text] [Related]
12. Historical review: ATP as a neurotransmitter.
Burnstock G
Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling and disorders of the central nervous system.
Burnstock G
Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
16. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
17. Adenosine and ATP receptors in the brain.
Burnstock G; Fredholm BB; Verkhratsky A
Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499
[TBL] [Abstract][Full Text] [Related]
18. Purinergic cotransmission.
Burnstock G
Exp Physiol; 2009 Jan; 94(1):20-4. PubMed ID: 18723580
[TBL] [Abstract][Full Text] [Related]
19. [Purinergic regulatory complex in the brain synapses].
Kato F; Imura T; Shigetomi E
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Jun; 27(3):117-26. PubMed ID: 17633523
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signaling involved in Müller cell function in the mammalian retina.
Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
